NCT06174415

Brief Summary

Ocular trauma is one of the leading causes of blindness worldwide, often resulting in severe visual impairment or even loss of vision after injury. Although after powerful surgical treatment, there are still some patients whose visual function is difficult to improve, and the patients with eye trauma lack effective vision rehabilitation therapy.Therefore, the research on visual function rehabilitation of patients with ocular trauma needs to be further carried out . Perceptual learning is based on cortical remodeling, repetitive visual task training. This training is to perform a series of repetitive visual tasks through the Gabor patch, simulating the receptive field structure of simple cells in the primary visual cortex (V1 area), "awakening visual cells", and improving the visual processing ability of the cerebral cortex. Compared with the traditional vision rehabilitation therapy, perceptual learning optimizes the visual quality at the visual center level. It is an innovative therapy, having the potential to solve the visual function of patients with eye trauma. This study intends to explore new visual rehabilitation methods for patients with ocular trauma, and explore the changes in visual cortical function and area of patients after perceptual training.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
12 days until next milestone

Study Start

First participant enrolled

December 30, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

December 18, 2023

Status Verified

May 1, 2023

Enrollment Period

4 months

First QC Date

December 8, 2023

Last Update Submit

December 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Best Corrected Visual Acuity

    Log MAR

    3 months

Secondary Outcomes (1)

  • Contrast Sensitivity Function

    3 months

Study Arms (1)

Experimental group

EXPERIMENTAL

The experimental group consisted of the patients themselves. Compare data before and after treatment

Device: Perceptual Learning

Interventions

Perceptual training is carried out at home once a day, and the viewing distance of the patients from the display screen is uniformly 1.5m, 30 minutes each time, for three months, and they return to the hospital for re-examination of ophthalmology at the 3rd months after the training. When using the perceptual training program for the first time, the training program will adjust the size of the Gabor spot according to the size of the user's computer, and prompt the patient to adjust the brightness of the computer screen to unify the Gabor spot parameters of each user and ensure the consistency of the spot stimulation information received by each user.

Experimental group

Eligibility Criteria

Age3 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Retinopathy, optic neuropathy, endophthalmitis and other injuries caused by ocular trauma, with varying degrees of central vision reduction and visual field impairment
  • Age 3\~60 years old
  • Best corrected visual acuity of the affected eye: 20/200≤BCVA≤20/25
  • Intraocular pressure is normal, non-hypotonal/atrophic: 7--21mmHg
  • After the traumatic injury, the condition is stable ≥for 3 months after treatment, and the visual axis has a complete and transparent optical pathway
  • If the patient is injured in one eye, There were no abnormal lesions in the contralateral eye, no abnormalities in slit lamp and indirect ophthalmoscopy, and no peripheral retinopathy in both eyes was found on triprimmoscopy. Carefully ask for a history of no other eye disease in both eyes and a systemic history that has caused an associated eye disease or has affected visual formation.
  • The cranial structure is intact, the function is good, and there is no primary or secondary injury
  • Able to cooperate with the questionnaire and treatment, good compliance
  • Those who are willing to sign the informed consent form

You may not qualify if:

  • Have active inflammation of the eye
  • Previous abnormal intraocular blood supply such as occlusion of the central intraocular artery due to trauma or non-traumatic factors
  • History of other non-traumatic intraocular surgery
  • Ocular related lesions caused by other non-traumatic factors that can interfere with this study, such as age-related macular degeneration, glaucoma, amblyopia, etc.
  • Use of other rehabilitation training methods or visual aids 3 months before enrollment
  • Lesions with systemic diseases whose degree of lesions have affected visual function, such as diabetic retinopathy, Hypertension and arteriosclerotic fundus changes, rubella-related ocular changes, etc.
  • Patients with severe systemic diseases such as renal failure and malignant hypertension or may affect visual function (such as retinal structure and function, choroidal structure and function, etc.)
  • Patients with congenital ocular lesions
  • Patients with optic nerve and retinopathy caused by non-traumatic factors
  • Patients with cranial brain disease or craniocere-related lesions with poor cortical function
  • Psychological related diseases
  • MRI contraindications, Such as claustrophobia and non-MRI compatible metal implants
  • people with speech impairment and intellectual disability
  • those who are considered inappropriate by the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhonshan Ophthalmic Center, Sun Yat-Sen University

Guangzhou, Guangdong, China

Location

MeSH Terms

Conditions

Eye Injuries

Condition Hierarchy (Ancestors)

Facial InjuriesCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesEye DiseasesWounds and Injuries

Study Officials

  • XUEYING ZHONGLIU

    Zhonshan Ophthalmic Center, Sun-Yat-sen University Organization

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Comparing the data before and after treatment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2023

First Posted

December 18, 2023

Study Start

December 30, 2023

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

December 18, 2023

Record last verified: 2023-05

Locations